GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

NCT04405375 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Extranodal NK/T-cell Lymphoma, Nasal Type

Interventions

DRUG: gemcitabin
DRUG: Pegaspargase
DRUG: Etoposide
DRUG: Dexamethasone

Sponsor

Beijing Tongren Hospital